Smoking worsens the prognosis of mild abnormalities in cervical cytology

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 5, 2009, Pages 514-520

  Guarisi, Renata ^a   Sarian, Luis Otavio ^a   Hammes, Luciano Serpa ^b   Longatto Filho, Adhemar ^c,d   Derchain, Sophie F M ^a   Roteli Martins, Cecília ^e   Naud, Paulo ^b   Eržen, Mojca ^f   Branca, Margherita ^g   Tatti, Silvio ^h   Costa, Silvano ⁱ   Syrjänen, Stina ^j   Bragança, Joana F ^a   Syrjänen, Kari ^k  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF MINHO   (Portugal)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

^e HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^f SIZE Diagnostic Center   (Slovenia)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j UNIVERSITY OF TURKU   (Finland)

^k TURKU UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Atypical squamous cells; Follow up; Low grade intraepithelial lesion

Indexed keywords

ADULT; ARGENTINA; ARTICLE; BRAZIL; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; CLASSIFICATION; CONFIDENCE INTERVAL; CYTOLOGY; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PAPILLOMA VIRUS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; COLPOSCOPY; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MULTIVARIATE ANALYSIS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 65649122345     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902846072     Document Type: Article

References (27)

1. Castellsague X, Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20-8.
2. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control. 2003;14:805-14.
3. Procopzyk B, Cox JE, Hoffman D, Waggoner SE. Identification of tobacco-specific carcinogens in the cervical mucus of smokers and non-smokers. J Nat Cancer Inst. 1997;89:868-73.
4. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang X, et al. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett. 1999;146:127-34.
5. Cox JT, Schiffman M, Solomon D, for the ALTS Group. Prospective follow-up suggest similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188:1406-12.
6. Guido R, Schiffman M, Solomon D, for the ALTS Group. Post colposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol. 2003;188:1383-92.
7. Walker JL, Wang SS, Schiffman M, Solomon D, for the ASCUS LSIL Triage Study (ALTS) Group. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol. 2006;195:341-8.
8. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, et al. HPV 16 and cigarette smoking as risk factors for highgrade cervical intra-epithelial neoplasia. Int J Cancer. 1998;78:281-5.
9. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24:S1/4-15.
10. Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Van Assche FA. Tobacco smoking impairs the local immunossur-veillance in the uterine cervix. Gynecol Obstet Invest. 1995;39:34-8.
11. Poppe WA, Peeters R, Drijkoningen MP, Ide PS, Daenens P, Lauweryns JM, Van Assche FA. Cervical cotinine and macrophage-Langerhans cell density in the normal uterine cervix. Gynecol Obstet Invest. 1996;41:253-9.
12. Ferson M, Edwards A, Lind A, Milton GW, Hersey P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer. 1979; 23:603-9.
13. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev. 2005;14:1165-70.
14. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, et al. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst. 1989;8:205-11.
15. Vaccarella S, Franceschi S, Herrero R, Munoz N, Snijders PJ, Clifford GM, et al. Sexual behaviour, condom use, and human papillomavirus infection: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev. 2006;15:326-33.
16. Syrjanen K, Naud P, Derchain S. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res. 2005;25:3469-80.
17. Longatto-Filho A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, et al. Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study. Int J Gynecol Cancer. 2006;16:955-62.
18. Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's Iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS study. J Med Screen. 2005;12:142-9.
19. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287: 2114-9.
20. Lörincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, et al. Viral load of human papillomavirus and risk of CIN 3 or cervical cancer. Lancet. 2002;360:288-9.
21. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available on: http://www.R-Project. org (accessed November 17 2008).
22. Tolstrup J, Munk C, Thomsen BL, Svare E, van den Brule AJ, Grønbaek M, et al. The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women. Acta Obstet Gynecol Scand. 2006;85:1114-19.
23. Matos A, Moutinho J, Pinto D, Medeiros R. The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur J Cancer Prev. 2005;14:485-91.
24. Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Cancer Prevalence Surveys. Int J Epidemiol. 2008; 37:536-46.
25. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-sponsored Consensus Conference: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA ;287. 2001;2002:2120-9.
26. Wright TC, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. ASCCP-sponsored Consensus Workshop: 2001 Consensus Guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189:295-394.
27. Syrjänen K, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, et al. Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol 2007;22: 723-35.